We found that the upgrade capacity of mDCs from AF patients to stimulate CD4+ and CD8+ T cells proliferations was restored, leading to results similar to that of normal mDCs (Fig.6; all P < 0.05). This evidence concerns the gene CD8A and atrial fibrillation.